Best TWAS P=7.76e-46 · Best GWAS P=1.06e-61 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | C19orf44 | 0.12 | 0.09 | bslmm | 400 | 0.13 | 2.1e-15 | 11.10 | -13.0 | 2.1e-38 | -0.58 | 0.99 | 0.01 | FALSE |
2 | GTEx | Adipose Subcutaneous | C19orf44 | 0.19 | 0.17 | lasso | 2 | 0.16 | 1.0e-12 | 10.48 | -10.2 | 2.5e-24 | -0.53 | 1.00 | 0.00 | FALSE |
3 | GTEx | Adipose Visceral Omentum | C19orf44 | 0.17 | 0.17 | enet | 4 | 0.17 | 5.6e-09 | 11.10 | -10.7 | 9.6e-27 | -0.54 | 1.00 | 0.00 | FALSE |
4 | GTEx | Artery Aorta | C19orf44 | 0.33 | 0.35 | lasso | 1 | 0.35 | 6.0e-20 | 10.48 | -10.5 | 1.1e-25 | -0.53 | 1.00 | 0.00 | FALSE |
5 | GTEx | Artery Tibial | C19orf44 | 0.27 | 0.25 | lasso | 3 | 0.26 | 5.6e-20 | 10.48 | -10.6 | 2.2e-26 | -0.53 | 1.00 | 0.00 | FALSE |
6 | GTEx | Artery Tibial | EPS15L1 | 0.09 | 0.01 | lasso | 8 | 0.04 | 4.4e-04 | 15.56 | 14.2 | 1.4e-45 | 0.64 | 0.08 | 0.16 | TRUE |
7 | GTEx | Artery Tibial | CTD-2538G9.5 | 0.09 | 0.00 | enet | 12 | 0.00 | 4.9e-01 | 9.44 | 5.5 | 4.5e-08 | 0.31 | 0.10 | 0.03 | FALSE |
8 | GTEx | Brain Frontal Cortex BA9 | C19orf44 | 0.27 | 0.22 | lasso | 1 | 0.19 | 1.0e-05 | 11.10 | -11.1 | 1.3e-28 | -0.55 | 0.22 | 0.16 | FALSE |
9 | GTEx | Breast Mammary Tissue | C19orf44 | 0.17 | 0.20 | enet | 6 | 0.21 | 2.8e-11 | 10.97 | -9.6 | 5.9e-22 | -0.50 | 1.00 | 0.00 | FALSE |
10 | GTEx | Breast Mammary Tissue (Male) | C19orf44 | 0.12 | 0.02 | lasso | 1 | 0.01 | 2.2e-01 | 11.10 | -11.1 | 1.3e-28 | -0.55 | 0.03 | 0.27 | FALSE |
11 | GTEx | Breast Mammary Tissue (Female) | C19orf44 | 0.21 | 0.02 | lasso | 2 | 0.06 | 6.7e-03 | 11.10 | -11.1 | 2.1e-28 | -0.55 | 0.12 | 0.08 | FALSE |
12 | GTEx | Breast Mammary Tissue (Female) | CTC-429P9.1 | 0.24 | 0.00 | enet | 32 | 0.02 | 8.9e-02 | 4.94 | 5.6 | 2.7e-08 | 0.34 | 0.04 | 0.25 | FALSE |
13 | GTEx | Cells Transformed fibroblasts | C19orf44 | 0.29 | 0.27 | lasso | 5 | 0.26 | 6.8e-20 | 10.48 | -10.3 | 5.6e-25 | -0.53 | 1.00 | 0.00 | FALSE |
14 | GTEx | Cells Transformed fibroblasts | MAP1S | 0.24 | 0.18 | enet | 24 | 0.14 | 4.9e-11 | -4.40 | -5.2 | 1.5e-07 | 0.00 | 0.24 | 0.74 | TRUE |
15 | GTEx | Cells Transformed fibroblasts | HAUS8 | 0.12 | 0.05 | enet | 19 | 0.05 | 1.0e-04 | 4.11 | -5.7 | 1.3e-08 | -0.04 | 0.75 | 0.01 | TRUE |
16 | GTEx | Colon Transverse | C19orf44 | 0.13 | 0.10 | enet | 15 | 0.08 | 1.7e-04 | 11.10 | -10.1 | 6.7e-24 | -0.48 | 0.30 | 0.08 | FALSE |
17 | GTEx | Esophagus Gastroesophageal Junction | C19orf44 | 0.27 | 0.30 | lasso | 1 | 0.27 | 3.9e-10 | 10.48 | -10.5 | 1.1e-25 | -0.53 | 0.98 | 0.01 | FALSE |
18 | GTEx | Esophagus Mucosa | C19orf44 | 0.12 | 0.09 | enet | 2 | 0.09 | 7.1e-07 | 4.88 | -7.4 | 1.1e-13 | -0.44 | 0.84 | 0.13 | FALSE |
19 | GTEx | Esophagus Muscularis | C19orf44 | 0.34 | 0.22 | enet | 12 | 0.23 | 4.6e-14 | 10.48 | -9.1 | 1.1e-19 | -0.44 | 1.00 | 0.00 | FALSE |
20 | GTEx | Esophagus Muscularis | EPS15L1 | 0.10 | 0.02 | enet | 18 | 0.04 | 1.6e-03 | 9.78 | 13.3 | 2.8e-40 | 0.43 | 0.20 | 0.34 | FALSE |
21 | GTEx | Heart Atrial Appendage | C19orf44 | 0.21 | 0.14 | lasso | 5 | 0.13 | 1.7e-06 | 11.10 | -9.1 | 1.4e-19 | -0.45 | 0.62 | 0.04 | FALSE |
22 | GTEx | Heart Left Ventricle | C19orf44 | 0.14 | 0.04 | enet | 11 | 0.04 | 2.6e-03 | 10.97 | -9.2 | 2.5e-20 | -0.45 | 0.12 | 0.22 | FALSE |
23 | GTEx | Muscle Skeletal | C19orf44 | 0.12 | 0.13 | lasso | 2 | 0.12 | 4.0e-12 | 11.10 | -11.1 | 2.1e-28 | -0.55 | 1.00 | 0.00 | FALSE |
24 | GTEx | Muscle Skeletal | SMIM7 | 0.09 | 0.00 | enet | 25 | 0.03 | 2.5e-04 | -0.31 | 6.5 | 9.4e-11 | 0.35 | 0.14 | 0.07 | FALSE |
25 | GTEx | Muscle Skeletal | CTC-429P9.5 | 0.09 | 0.01 | enet | 22 | 0.01 | 4.7e-02 | -0.31 | 5.7 | 1.1e-08 | 0.19 | 0.08 | 0.12 | FALSE |
26 | GTEx | Muscle Skeletal | CTC-429P9.1 | 0.09 | 0.00 | enet | 18 | 0.02 | 3.8e-03 | -0.46 | 5.3 | 1.4e-07 | 0.25 | 0.19 | 0.04 | TRUE |
27 | GTEx | Nerve Tibial | C19orf44 | 0.28 | 0.24 | enet | 11 | 0.25 | 4.5e-18 | 10.48 | -11.3 | 2.3e-29 | -0.54 | 1.00 | 0.00 | FALSE |
28 | GTEx | Nerve Tibial | CTC-429P9.3 | 0.13 | 0.02 | enet | 15 | 0.03 | 3.6e-03 | 8.90 | -5.9 | 2.8e-09 | -0.32 | 0.08 | 0.18 | FALSE |
29 | GTEx | Ovary | C19orf44 | 0.26 | 0.17 | lasso | 3 | 0.21 | 8.8e-06 | 10.48 | -14.0 | 2.0e-44 | -0.63 | 0.24 | 0.13 | TRUE |
30 | GTEx | Skin Sun Exposed Lower leg | C19orf44 | 0.15 | 0.11 | enet | 8 | 0.11 | 1.5e-09 | 11.10 | -9.9 | 2.6e-23 | -0.52 | 1.00 | 0.00 | FALSE |
31 | GTEx | Thyroid | C19orf44 | 0.16 | 0.13 | lasso | 1 | 0.13 | 5.1e-10 | 11.10 | -11.1 | 1.3e-28 | -0.55 | 1.00 | 0.00 | FALSE |
32 | METSIM | Adipose | C19orf44 | 0.12 | 0.15 | enet | 18 | 0.15 | 5.0e-22 | 11.10 | -11.6 | 4.6e-31 | -0.56 | 1.00 | 0.00 | FALSE |
33 | METSIM | Adipose | EPS15L1 | 0.04 | 0.02 | lasso | 4 | 0.02 | 2.8e-04 | 15.54 | 14.0 | 1.3e-44 | 0.60 | 0.43 | 0.02 | FALSE |
34 | METSIM | Adipose | FCHO1 | 0.05 | 0.03 | lasso | 3 | 0.04 | 2.1e-06 | 4.17 | -5.2 | 2.5e-07 | 0.01 | 0.35 | 0.61 | FALSE |
35 | METSIM | Adipose | SLC35E1 | 0.12 | 0.02 | enet | 38 | 0.06 | 1.9e-09 | 15.54 | 11.6 | 3.4e-31 | 0.47 | 0.69 | 0.01 | TRUE |
36 | NTR | Blood | LRRC25 | 0.03 | 0.01 | lasso | 4 | 0.01 | 2.9e-04 | 6.52 | -5.9 | 3.7e-09 | -0.07 | 0.00 | 0.99 | FALSE |
37 | ROSMAP | Brain Pre-frontal Cortex | C19orf44 | 0.18 | 0.14 | enet | 18 | 0.15 | 1.1e-18 | 10.97 | -13.5 | 2.2e-41 | -0.65 | 1.00 | 0.00 | TRUE |
38 | ROSMAP | Brain Pre-frontal Cortex | ATP13A1 | 0.10 | 0.07 | lasso | 5 | 0.06 | 1.3e-08 | 5.45 | -5.2 | 1.8e-07 | 0.00 | 0.00 | 1.00 | TRUE |
39 | YFS | Blood | LRRC25 | 0.35 | 0.19 | enet | 24 | 0.32 | 9.5e-108 | 6.52 | -7.6 | 3.6e-14 | -0.04 | 0.00 | 1.00 | TRUE |
40 | YFS | Blood | SLC35E1 | 0.04 | 0.02 | bslmm | 349 | 0.02 | 8.2e-08 | 9.39 | 11.3 | 8.2e-30 | 0.39 | 0.93 | 0.00 | TRUE |
41 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C19orf44 | 0.05 | 0.02 | enet | 3 | 0.01 | 8.4e-02 | 10.97 | -10.4 | 1.8e-25 | -0.53 | 0.14 | 0.19 | FALSE |
42 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C19orf44 | 0.05 | 0.06 | lasso | 1 | 0.06 | 1.1e-12 | 11.10 | -11.1 | 1.3e-28 | -0.55 | 1.00 | 0.00 | FALSE |
43 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LRRC25 | 0.06 | 0.07 | enet | 13 | 0.06 | 5.9e-13 | 6.37 | -5.1 | 3.1e-07 | -0.03 | 0.00 | 1.00 | FALSE |
44 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | LRRC25 | 0.14 | 0.07 | enet | 5 | 0.10 | 8.3e-06 | 6.52 | -5.3 | 1.4e-07 | -0.05 | 0.00 | 0.99 | FALSE |
45 | The Cancer Genome Atlas | Colon Adenocarcinoma | C19orf44 | 0.16 | 0.12 | enet | 6 | 0.12 | 3.2e-07 | 10.97 | -9.7 | 4.2e-22 | -0.49 | 0.98 | 0.00 | FALSE |
46 | The Cancer Genome Atlas | Colon Adenocarcinoma | LRRC25 | 0.06 | 0.05 | blup | 44 | 0.04 | 1.5e-03 | 4.26 | -5.5 | 4.2e-08 | -0.06 | 0.11 | 0.25 | FALSE |
47 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C19orf44 | 0.07 | 0.06 | lasso | 3 | 0.06 | 1.7e-07 | 11.10 | -11.2 | 4.7e-29 | -0.55 | 0.92 | 0.02 | FALSE |
48 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C19orf44 | 0.22 | 0.19 | blup | 44 | 0.20 | 9.4e-22 | 10.97 | -8.8 | 1.4e-18 | -0.48 | 1.00 | 0.00 | FALSE |
49 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C19orf44 | 0.13 | 0.05 | blup | 44 | 0.07 | 5.3e-05 | 10.97 | -9.8 | 1.8e-22 | -0.52 | 0.60 | 0.09 | FALSE |
50 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C19orf44 | 0.10 | 0.09 | lasso | 2 | 0.09 | 6.3e-10 | 11.10 | -11.2 | 3.7e-29 | -0.55 | 1.00 | 0.00 | FALSE |
51 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SSBP4 | 0.03 | 0.03 | lasso | 1 | 0.03 | 9.7e-05 | 6.37 | -6.4 | 1.9e-10 | -0.08 | 0.00 | 1.00 | FALSE |
52 | The Cancer Genome Atlas | Lung Adenocarcinoma | PGPEP1 | 0.03 | 0.01 | blup | 55 | 0.02 | 1.1e-03 | 4.50 | 5.6 | 2.7e-08 | 0.03 | 0.05 | 0.03 | FALSE |
53 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C19orf44 | 0.10 | 0.07 | lasso | 3 | 0.06 | 8.2e-08 | 10.97 | -10.9 | 1.2e-27 | -0.55 | 0.98 | 0.02 | FALSE |
54 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C19orf44 | 0.10 | 0.05 | blup | 44 | 0.07 | 1.7e-05 | 15.56 | -14.2 | 7.8e-46 | -0.63 | 0.02 | 0.92 | FALSE |
55 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SSBP4 | 0.06 | 0.02 | blup | 37 | 0.05 | 4.3e-04 | 4.32 | -6.1 | 1.0e-09 | -0.05 | 0.11 | 0.22 | FALSE |
56 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C19orf44 | 0.09 | 0.03 | enet | 5 | 0.03 | 1.5e-02 | 15.54 | -13.4 | 9.5e-41 | -0.60 | 0.02 | 0.33 | FALSE |
57 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | C19orf44 | 0.23 | 0.06 | enet | 19 | 0.08 | 3.7e-04 | 4.88 | -5.3 | 1.2e-07 | -0.37 | 0.06 | 0.16 | FALSE |
58 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C19orf44 | 0.23 | 0.27 | lasso | 4 | 0.27 | 3.1e-28 | 11.10 | -11.5 | 2.2e-30 | -0.56 | 1.00 | 0.00 | FALSE |
59 | The Cancer Genome Atlas | Prostate Adenocarcinoma | HAUS8 | 0.13 | 0.10 | blup | 55 | 0.11 | 7.8e-12 | 4.11 | -5.3 | 9.2e-08 | -0.03 | 0.25 | 0.62 | FALSE |
60 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | C19orf44 | 0.12 | 0.01 | blup | 45 | 0.09 | 2.3e-03 | 10.19 | -12.6 | 1.4e-36 | -0.49 | 0.01 | 0.46 | FALSE |
61 | The Cancer Genome Atlas | Stomach Adenocarcinoma | C19orf44 | 0.07 | 0.02 | lasso | 2 | 0.01 | 2.7e-02 | 9.92 | -11.8 | 6.6e-32 | -0.48 | 0.11 | 0.10 | FALSE |
62 | The Cancer Genome Atlas | Stomach Adenocarcinoma | PGPEP1 | 0.04 | 0.01 | blup | 56 | 0.03 | 3.1e-03 | -1.55 | 5.6 | 1.7e-08 | 0.02 | 0.06 | 0.06 | FALSE |
63 | The Cancer Genome Atlas | Thyroid Carcinoma | C19orf44 | 0.18 | 0.19 | lasso | 2 | 0.18 | 2.2e-17 | 11.10 | -10.9 | 8.8e-28 | -0.54 | 1.00 | 0.00 | FALSE |
64 | The Cancer Genome Atlas | Thyroid Carcinoma | CHERP | 0.03 | 0.00 | blup | 51 | 0.01 | 2.8e-02 | 10.19 | 10.8 | 3.5e-27 | 0.31 | 0.02 | 0.34 | TRUE |
65 | The Cancer Genome Atlas | Thyroid Carcinoma | LRRC25 | 0.05 | 0.08 | lasso | 3 | 0.07 | 5.4e-07 | 6.52 | -6.3 | 3.1e-10 | -0.07 | 0.00 | 1.00 | FALSE |